Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing ...
Qure (NasdaqGS:QURE) released updated clinical data for its gene therapy candidate AMT-191 in Fabry disease and paused new dosing to review safety findings. The company is also facing a newly filed ...
HONG KONG SAR, HONG KONG, February 2, 2026 /EINPresswire.com/ -- Mstone Partners Healthcare (“Mstone”), a Hong ...
Dr. Rob Burgess shares how Sino Biological empowers global biomedical research through precision, quality, and ...
Guggenheim Securities Emerging Outlook: Biotech Summit 2026 February 12, 2026 12:30 PM ESTCompany ParticipantsR.
According to MarketsandMarkets™, the Leukapheresis Market is projected to grow from about USD 90.6 million in 2026 to USD 138.7 million ...
Vietnam Investment Review on MSN
APAO 2026 ophthalmology congress wraps successfully
HONG KONG SAR - Media OutReach Newswire - 13 February 2026 - The four-day "APAO 2026 Asia-Pacific Academy of Ophthalmology (APAO) Congress" successfully concluded last week, marking a significant ...
HONG KONG SAR - Media OutReach Newswire - 13 February 2026 - The four-day "APAO 2026 Asia-Pacific Academy of Ophthalmology ...
Madrigal is eying an expansion of MASH blockbuster Rezdiffra’s capabilities via combination with precision siRNA gene ...
According to MarketsandMarkets, the Leukapheresis Market is projected to grow from about USD 90.6 million in 2026 to USD 138.7 million by 2031 ...
The guidance encourages the use of Bayesian statistics in drug trials. Instead of starting from scratch and only adding new ...
The recently passed federal defense budget for 2026 includes dedicated funding for the use of bioengineered blood vessels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results